Development and commercialization of medicines
Roivant Sciences has raised €1.1B across 2 funding rounds from 1 investor, most recently a round in Nov 2018. Based in Basel, Switzerland; active in Healthtech. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2018-11-13 | Other | €178M | — | View deal → |
| 2017-08-11 | Growth/Late | €938M | SoftBank | View deal → |
